Sponsor or institution
Clinical trials and research at Italfarmaco
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Italfarmaco that are recruiting, at sites in 20 countries (most in Italy (4), Netherlands (4), United Kingdom (4)). By phase: Phase 3 (2), Phase 2 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 20Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Evaluating Givinostat for Young Children with Duchenne Muscular Dystrophy | Phase 2 | Brussels and 8 other locations | Recruiting | Jan 10, 2025 |
| Comparing givinostat and hydroxyurea for treating polycythemia vera | Phase 3 | Birmingham, Alabama and 89 other locations | Recruiting | Oct 23, 2023 |
| Evaluating the effects of givinostat in boys with Duchenne muscular dystrophy who cannot walk | Phase 3 | Leuven and 28 other locations | Recruiting | Jul 6, 2023 |
| Long-term Givinostat treatment for safety and tolerability in Duchenne muscular dystrophy | Phase 2/3 | Sacramento, California and 38 other locations | Recruiting | Dec 14, 2017 |
All recruiting trials (4)
-
Evaluating Givinostat for Young Children with Duchenne Muscular Dystrophy
This study is testing a new drug called Givinostat to see if it's safe and how it works in young children aged 2 to 6 with Duchenne Muscular Dystrophy.
-
Comparing givinostat and hydroxyurea for treating polycythemia vera
This study is testing whether givinostat works better than hydroxyurea for treating high-risk polycythemia vera in patients with a specific genetic mutation.
-
Evaluating the effects of givinostat in boys with Duchenne muscular dystrophy who cannot walk
This study is testing if a new drug called givinostat can help boys with Duchenne muscular dystrophy who can't walk by slowing down muscle decline over 18 months.
-
Long-term Givinostat treatment for safety and tolerability in Duchenne muscular dystrophy
This long-term treatment will try Givinostat in people with Duchenne muscular dystrophy who previously took the drug to see if it remains safe and tolerable.
Quick answers
How many clinical trials run by Italfarmaco are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 20 countries. The most sites are in Italy (4 trials), Netherlands (4 trials), United Kingdom (4 trials), Belgium (3 trials), France (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.